Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2026-01-29 @ 1:15 AM
Study NCT ID:
NCT06990503
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-05-25
First Post:
2025-05-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer
Sponsor:
Tongji Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2030-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2035-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-18
First Submit QC Date:
None
Study First Post Date:
2025-05-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-18
Last Update Post Date:
2025-05-25
Last Update Post Date Type:
ACTUAL